Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study
Go back to Arrowhead Pauses ARO-ENaC Phase 1/2 Clinical Study| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 81.68 -1.17 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.85 | 52 Week High | $8.22 | |||
| Open | $82.98 | 52 Week Low | $3.07 | |||
| Day High | $83.27 | P/E | N/A | |||
| Day Low | $81.02 | EPS | $-1.30 | |||
| Volume | 260,142 | |||||
